Mitochondrial dysfunction in neocortex and hippocampus of olfactory bulbectomized mice, a model of Alzheimer’s disease

Biochemistry (Moscow)

Volumn 81, Issue 6, 2016, Pages 615-623

  Avetisyan, A V ^a   Samokhin, A N ^b   Alexandrova, I Y ^b   Zinovkin, R A ^a   Simonyan, R A ^a   Bobkova, N V ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

Author keywords

Alzheimer s disease; mitochondrial dysfunction; olfactory bulbectomized mice; oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; CYTOCHROME C OXIDASE; MULTIENZYME COMPLEX; OXIDOREDUCTASE; PEPTIDE FRAGMENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ALZHEIMER DISEASE; ANIMAL; DISEASE MODEL; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NEOCORTEX; OLFACTORY BULB; OXIDATIVE STRESS; PATHOLOGY; SPATIAL MEMORY; SURGERY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; NEOCORTEX; OLFACTORY BULB; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES; SPATIAL MEMORY;

EID: 84975782094     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297916060080     Document Type: Article

References (44)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics, Science, 297, 353–356.
2. Atwood, C. S., and Bowen, R. L. (2015) A unified hypothesis of earlyand late-onset Alzheimer’s disease pathogenesis, J. Alzheimer’s Dis., 47, 33–47.
3. Bobkova, N. V., Nesterova, I. V., Medvinskaya, N. I., Aleksandrova, I. Y., Samokhin, A. N., Gershovich, Y. G., Gershovich, P. M., and Yashin, V. A. (2005) Possible role of olfactory system in Alzheimer’s disease genesis, in Alzheimer’s and Parkinson’s Disease–AD/PD (Hanin, L., and Fisher, A., eds.) Monduzzi Medimond, pp. 91–95.
4. Walsh, D. M., and Selkoe, D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer’s disease, Neuron, 44, 181–193.
5. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science, 300, 486489.
6. Bobkova, N. V., Nesterova, I. V., Dana, R., Dana, E., Nesterov, V. I., Aleksandrova, I. Y., Medvinskaya, N. I., and Samokhin, A. N. (2004) Morphofunctional changes in neurons in the temporal cortex of the brain in relation to spatial memory in bulbectomized mice after treatment with mineral ascorbates, Neurosci. Behav. Physiol., 34, 671–676.
7. Hu, J., Wang, X., Liu, D., Wang, Q., and Zhu, L. Q. (2012) Olfactory deficits induce neurofilament hyperphosphorylation, Neurosci. Lett., 506, 180–183.
8. Hozumi, S., Nakagawasai, O., Tan-No, K., Niijima, F., Yamadera, F., Murata, A., Arai, Y., Yasuhara, H., and Tadano, T. (2003) Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy, Behav. Brain Res., 138, 9–15.
9. Moriguchi, S., Han, F., Nakagawasai, O., Tadano, T., and Fukunaga, K. M. (2006) Decreased calcium/calmodulindependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice, J. Neurochem., 97, 22–29.
10. Wang, X., Wang, W., Li, L., Perry, G., Lee, H. G., and Zhu, X. (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease, Biochim. Biophys. Acta, 1842, 12401247.
11. Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., and Reddy, P. H. (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression, Hum. Mol. Genet., 15, 1437–1449.
12. Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., and Brinton, R. D. (2009) Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 106, 14670–14675.
13. Schmitt, K., Grimm, A., Kazmierczak, A., Strosznajder, J. B., Gotz, J., and Eckert, A. (2012) Insights into mitochondrial dysfunction: aging, amyloid-ß, and tau–a deleterious trio, Antioxid. Redox Signal., 16, 1456–1466.
14. Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., and Ankarcrona, M. (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae, Proc. Natl. Acad. Sci. USA, 105, 13145–13150.
15. Eckert, A., Schmitt, K., and Gotz, J. (2011) Mitochondrial dysfunction–the beginning of the end in Alzheimer’s disease? Separate and synergistic modes of tau and amyloid-ß toxicity, Alzheimer’s Res. Ther., 3, 15.
16. Rhein, V., Baysang, G., Rao, S., Meier, F., Bonert, A., Muller-Spahn, F., and Eckert, A. (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells, {iCell. Mol. Neurobiol.}, 29, 1063–1071.
17. Hroudova, J., Singh, N., and Fisar, Z. (2014) Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer’s disease, Biomed. Res. Int., 17 50–62.
18. Kamynina, A. V., Volpina, O. M., Medvinskaya, N. I., Aleksandrova, I. Ju., Volkova, T. D., and Koroev, D. O. (2010) Vaccination with peptide 173-193 of acetylcholine receptor a7-subunit prevents memory loss in olfactory bulbectomized mice, J. Alzheimer’s Dis., 21, 249–261.
19. Chinopoulos, C., Zhang, S. F., Thomas, B., Ten, V., and Starkov, A. A. (2011) Isolation and functional assessment of mitochondria from small amounts of mouse brain tissue, Methods Mol. Biol., 793, 311–324.
20. Krumschnabel, G., Eigentler, A., Fasching, M., and Gnaiger, E. (2014) Use of safranin for the assessment of mitochondrial membrane potential by high-resolution respirometry and fluorometry, Methods Enzymol., 542, 163–181.
21. Jentzsch, A. M., Bachmann, H., Furst, P., and Biesalski, H. K. (1996) Improved analysis of malondialdehyde in human body fluids, Free Radic. Biol. Med., 20, 251–256.
22. Aleksandrova, I. Yu., Kuvichkin, V. V., Kashparov, I. V., Medvinskaya, N. I., Nesterova, I. V., Lunin, S. V., Samokhin, A. N., and Bobkova, N. V. (2004) Increased levels of beta-amylod protein in the brain of bulbectomized mice, Biochemistry (Moscow), 69, 176–180.
23. Cha, M. Y., Han, S. H., Son, S. M., Hong, H. S., Choi, Y. J., Byun, J., and Mook-Jung, I. (2012) Mitochondria-specific accumulation of amyloid ß induces mitochondrial dysfunction leading to apoptotic cell death, {iPLoS One}, 7, e34929.
24. Parker, W. D., Jr., Parks, J., Filley, C. M., and Kleinschmidt-DeMasters, B. K. (1994) Electron transport chain defects in Alzheimer’s disease brain, Neurology, 44, 1090–1096.
25. Du, H., Guo, L., Yan, S., Sosunov, A. A., McKhann, G. M., and Yan, S. S. (2010) Early deficits in synaptic mitochondria in an Alzheimer’s disease mouse model, Proc. Natl. Acad. Sci. USA, 107, 18670–18675.
26. Wilson, D. F., and Vinogradov, S. A. (2014) Mitochondrial cytochrome c oxidase: mechanism of action and role in regulating oxidative phosphorylation, J. Appl. Physiol., 117, 1431–1439.
27. Cardoso, S. M., Proenca, M. T., Santos, S., Santana, I., and Oliveira, C. R. (2004) Cytochrome c oxidase is decreased in Alzheimer’s disease platelets, Neurobiol. Aging, 25, 105–110.
28. Maurer, I., Zierz, S., and Moller, H. J. (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer’s disease patients, Neurobiol. Aging, 21, 455462.
29. Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Drose, S., Brandt, U., Savaskan, E., Czech, C., Gotz, J., and Eckert, A. (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice, Proc. Natl. Acad. Sci. USA, 106, 20057–20062.
30. Ma, T., Hoeffer, C. A., Wong, H., Maßsaad, C. A., Zhou, P., Iadecola, C., Murphy, M. P., Pautler, R. G., and Klann, E. (2011) Amyloid ß-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide, J. Neurosci., 31, 5589–5595.
31. Serra, J. A., Dominguez, R. O., Marschoff, E. R., Guareschi, E. M., Famulari, A. L., and Boveris, A. (2009) Systemic oxidative stress associated with the neurological diseases of aging, Neurochem. Res., 34, 2122–2132.
32. Devanand, D. P., Lee, S., Manly, J., Andrews, H., Schupf, N., Doty, R. L., Stern, Y., Zahodne, L. B., Louis, E. D., and Mayeux, R. (2015) Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community, Neurology, 84, 182–189.
33. Bobkova, N., Guzhova, I., Margulis, B., Nesterova, I., Medvinskaya, N., Samokhin, A., Alexandrova, I., Garbuz, D., Nudler, E., and Evgen’ev, M. (2013) Dynamics of endogenous Hsp70 synthesis in the brain of olfactory bulbectomized mice, Cell Stress Chaperones, 18, 109–118.
34. Nesterova, I. V., Bobkova, N. V., Medvinskaya, N. I., Samokhin, A. N., and Aleksandrova, I. Y. (2008) Morphofunctional state of neurons in the temporal cortex and hippocampus in relation to the level of spatial memory in rats after ablation of the olfactory bulbs, Neurosci. Behav. Physiol., 38, 349–353.
35. Swerdlow, R. H., Burns, J. M., and Khan, S. M. (2010) The Alzheimer’s disease mitochondrial cascade hypothesis, J. Alzheimer’s Dis., 20, Suppl. 2, S265–279.
36. Aleardi, A. M., Benard, G., Augereau, O., Malgat, M., Talbot, J. C., Mazat, J. P., Letellier, T., Dachary-Prigent, J., Solaini, G. C., and Rossignol, R. (2005) Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release, J. Bioenerg. Biomembr., 37, 207–225.
37. Bobkova, N. V. (2010) Bulbectomized animals as models for sporadic Alzheimer’s desease, in Neurodegenerative Disorders: Fundamental Aspects and Applications (Ugryumov, M. V., ed.) [in Russian], Nauka, Moscow, pp. 341–349.
38. Mutisya, E. M., Bowling, A. C., and Beal, M. F. (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease, J. Neurochem., 63, 2179–2184.
39. Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q. X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., Masters, C. L., and Trounce, I. A. (2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42, J. Neurosci., 19, 672–679.
40. Pedros, I., Petrov, D., Allgaier, M., Sureda, F., Barroso, E., Beas-Zarate, C., Auladell, C., Pallas, M., VazquezCarrera, M., Casadesus, G., Folch, J., and Camins, A. (2014) Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer’s disease, Biochim. Biophys. Acta, 1842, 15561566.
41. Schauerte, J. A., Wong, P. T., Wisser, K. C., Ding, H., Steel, D. G., and Gafni, A. (2010) Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers, Biochemistry, 13, 30313039.
42. Greilberger, J., Koidl, C., Greilberger, M., Lamprecht, M., Schroecksnadel, K., Leblhuber, F., Fuchs, D., and Oettl, K. (2008) Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer’s disease, Free Radic. Res., 42, 633–638.
43. Hernandez-Zimbron, L. F., and Rivas-Arancibia, S. (2015) Oxidative streßs caused by ozone exposure induces ß-amyloid 1-42 overproduction and mitochondrial accumulation by activating the amyloidogenic pathway, Neuroscience, 304, 340–348.
44. Jiao, Y., Zhang, Y., Wei, Y., Liu, Z., An, W., and Guo, M. (2012) Direct observation of internalization and ROS generation of amyloid ß-peptide in neuronal cells at subcellular resolution, ChemBioChem, 13, 2335–2338.